Results 1 to 10 of about 1,916,251 (255)

Aneurysmal subarachnoid hemorrhage in patients taking direct oral anticoagulants: A case series and discussion of management

open access: yesInterdisciplinary Neurosurgery, 2018
Direct oral anticoagulants are becoming more commonplace for the treatment of nonvalvular atrial fibrillation and deep vein thrombosis. Unfortunately, effective reversal agents are not widely available limiting options for neurosurgical intervention ...
Joseph H. McMordie, MD   +3 more
doaj   +2 more sources

Intracranial hemorrhage in the era of the “direct” oral anticoagulants [PDF]

open access: yesRomanian Journal of Neurology, 2019
Intracranial hemorrhage (ICH) is the most severe complication in patients treated with oral anticoagulants (OACs). Duration of anticoagulant therapy and poor anticoagulation control are important factors for hemorrhagic risk.
Ileana Raluca Nistor, Leonida Gherasim
doaj   +3 more sources

Using the CHOPS score to evaluate the severe cerebral venous sinus thrombosis progression risk after anticoagulation [PDF]

open access: yesFrontiers in Neurology
ObjectiveThis aimed to evaluate the risk of severe cerebral venous sinus thrombosis (SCVST) progression after anticoagulation using clinical and radiological data.MethodsClinical and radiological data from 199 SCVST patients were collected and analyzed ...
Ya-Qi Liu   +5 more
doaj   +2 more sources

Improved Cardiovascular Tolerance to Hemorrhage after Oral Resveratrol Pretreatment in Dogs [PDF]

open access: yesVeterinary Sciences, 2021
Resveratrol has been shown to preserve organ function and improve survival in hemorrhagic shock rat models. This study investigated whether seven days of oral resveratrol could improve hemodynamic response to hemorrhage and confer benefits on risk of ...
Jennifer Davis   +5 more
doaj   +2 more sources

Management of intractable oronasal bleeding using Sengstaken-Blakemore tubes in patients with facial trauma: a case series and technical notes [PDF]

open access: yesClinical and Experimental Emergency Medicine, 2021
Objective Intractable massive oronasal bleeding can become a life-threatening condition. The success rate of conventional bleeding control methods other than transarterial embolization (TAE) is not expected to be high.
Gi Woon Kim   +5 more
doaj   +1 more source

Transcatheter arterial chemoembolization is safe and effective for patients with late-stage or recurrent oral carcinoma

open access: yesFrontiers in Oncology, 2022
ObjectiveWe reported the long-term outcomes of transcatheter chemoembolization (TACE) for patients with late-stage or recurrent oral carcinoma.MethodsThis retrospective study enrolled 18 patients with late-stage or recurrent oral carcinoma between ...
Yonghua Bi   +7 more
doaj   +1 more source

Efficacy and safety of anticoagulation in atrial fibrillation patients with intracranial hemorrhage: A systematic review and meta-analysis

open access: yesFrontiers in Pharmacology, 2023
Background: The benefits and risks of starting anticoagulation therapy, such as direct oral anticoagulations (DOACs) or warfarin, in atrial fibrillation (AF) patients with a history of intracranial hemorrhage (ICH) remain controversial.
Qiang Zhou   +6 more
doaj   +1 more source

Low-Dose NOACs Versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Asian Patients with NVAF: A Meta-Analysis

open access: yesAnatolian Journal of Cardiology, 2022
Background: The meta-analysis of randomized controlled trials has illustrated that the efficacy of low-dose non-vitamin K antagonist oral anticoagulants is inferior compared with standard-dose non-vitamin K antagonist oral anticoagulants, though they are
Zei Li   +6 more
doaj   +1 more source

Management of Oral Anti-Thrombotic Agents Associated Intracerebral Hemorrhage [PDF]

open access: yesJournal of Neurocritical Care, 2016
Oral anti-thrombotic agents including anti-coagulants or anti-platelet agents are widely used to prevent cerebral infarction in patients with certain risk factors for ischemic stroke. Oral anti-coagulants, particularly warfarin, have long been used after
Yoonkyung Chang   +2 more
doaj   +1 more source

Non-vitamin K oral anticoagulants (NOACs) in patients with stroke and atrial fibrillation [PDF]

open access: yesArhiv za farmaciju, 2020
Patients with atrial fibrillation who had a previous transient ischemic attack or ischemic stroke had a significantly high risk of stroke recurrence and the introduction of oral anticoagulants should be mandatory.
Jovanović Dejana R.
doaj   +1 more source

Home - About - Disclaimer - Privacy